Zovia 1/35
Product Images NDC 53002-1591

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zovia 1/35 (NDC 53002-1591). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of the active ingredient in Zovia 1/35. The diagram shows a steroid-like molecular structure with labeled atoms including carbon (CH3), oxygen (O), and hydrogen (H) groups arranged in rings and chains. It represents the active compound's detailed molecular geometry.*

FDA Label Image

Image 2

Chemical structure of the active ingredient shown on the label of Zovia 1/35 by RPK Pharmaceuticals, Inc. The diagram displays a steroid backbone with hydroxyl, methyl, and ethynyl functional groups.*

FDA Label Image

Image 3

A bar chart showing mortality rates by age groups (15-24, 25-34, 35-44, 45+) comparing four populations: ever-users nonsmokers, ever-users smokers, controls nonsmokers, and controls smokers. Mortality rates increase significantly with age, especially among ever-users who smoke in the 45+ age group.*

FDA Label Image

Image 4

Zovia 1/35 blister pack containing ethynodiol diacetate and ethinyl estradiol tablets, labeled for a 28-day cycle. The pack is organized by day of the week in a 4-row by 7-column grid, with round tablets in each slot. It includes storage instructions and dosage guidance on the label. The labeler is RPK Pharmaceuticals, Inc.*

FDA Label Image

Label Image (Lbl530021591)

Zovia 1/35 tablets 28 day package label containing 28 tablets. The label includes instructions to take one tablet daily as directed and provides patient and prescription information areas. The product is labeled by RPK Pharmaceuticals, Inc. and includes the product NDC 53002-1591.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.